tetraethylammonium has been researched along with naloxone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelly, MJ; Loose, MD; Ronnekleiv, OK | 1 |
| Chalazonitis, A; Crain, SM; Shen, KF | 1 |
| Altes, U; Baur, AM; Hobbach, HP; Jost, D; Racké, K; Schäfer, J; Wammack, R | 1 |
| Malhotra, RK; Wakade, AR | 1 |
| Hough, C; Mazorow, DL; Millar, DB | 1 |
| Hata, F; Nishio, H; Nishiwaki, H; Saitoh, N; Takeuch, T | 1 |
| Castañeda-Hernández, G; Castro-Olguín, J; Ortiz, MI; Peña-Samaniego, N | 1 |
7 other study(ies) available for tetraethylammonium and naloxone
| Article | Year |
|---|---|
Membrane properties and response to opioids of identified dopamine neurons in the guinea pig hypothalamus.
Topics: Action Potentials; Animals; Cell Membrane; Dopamine; Electric Conductivity; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Estradiol; Female; Guinea Pigs; Hypothalamus; In Vitro Techniques; Male; Membrane Potentials; Naloxone; Neurons; Ovariectomy; Tetraethylammonium; Tetraethylammonium Compounds; Tetrodotoxin; Tyrosine 3-Monooxygenase | 1990 |
Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures.
Topics: Action Potentials; Animals; Barium; Calcium; Cesium; Chlorides; Dynorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fetus; Ganglia, Spinal; Ion Channels; Mice; Naloxone; Neurons, Afferent; Organ Culture Techniques; Potassium; Tetraethylammonium; Tetraethylammonium Compounds | 1988 |
Differential effects of potassium channel blockers on neurohypophysial release of oxytocin and vasopressin. Evidence for frequency-dependent interaction with the endogenous opioid inhibition of oxytocin release.
Topics: 4-Aminopyridine; Amifampridine; Aminopyridines; Animals; Benzopyrans; Cromakalim; Electric Stimulation; Endorphins; Female; Naloxone; Oxytocin; Pituitary Gland, Posterior; Potassium Channels; Pyrroles; Radioimmunoassay; Rats; Rats, Inbred Strains; Tetraethylammonium; Tetraethylammonium Compounds; Vasopressins | 1988 |
Non-cholinergic component of rat splanchnic nerves predominates at low neuronal activity and is eliminated by naloxone.
Topics: Acetylcholine; Adrenal Glands; Animals; Atropine; Catecholamines; Dose-Response Relationship, Drug; Electric Stimulation; Male; Mecamylamine; Naloxone; Rats; Receptors, Muscarinic; Receptors, Nicotinic; Splanchnic Nerves; Tetraethylammonium; Tetraethylammonium Compounds | 1987 |
The K channel blocker, tetraethylammonium, displaces beta-endorphin and naloxone from T-cell binding sites.
Topics: beta-Endorphin; Binding Sites; Binding, Competitive; Calcium Channel Blockers; Charybdotoxin; Electrophysiology; Mitogens; Naloxone; Narcotic Antagonists; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-myc; Quaternary Ammonium Compounds; T-Lymphocytes; Tetraethylammonium; Tetraethylammonium Compounds; Tumor Cells, Cultured | 1997 |
Possible role of potassium channels in mu-receptor-mediated inhibition and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum.
Topics: 4-Aminopyridine; Acetylcholine; Analgesics, Opioid; Animals; Apamin; Atropine; Drug Interactions; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Glyburide; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Muscarinic Antagonists; Myenteric Plexus; Naloxone; Narcotic Antagonists; Neuromuscular Junction; Peptides; Potassium Channel Blockers; Potassium Channels; Receptors, Muscarinic; Receptors, Opioid, mu; Tetraethylammonium | 2000 |
Probable activation of the opioid receptor-nitric oxide-cyclic GMP-K+ channels pathway by codeine.
Topics: 4-Aminopyridine; Analgesics, Opioid; Animals; Codeine; Cyclic GMP; Female; Glyburide; Methylene Blue; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Rats; Rats, Wistar; Receptors, Opioid; Tetraethylammonium; Tolbutamide | 2005 |